In 2003 Blazar et al. investigated the OX40 regulation of GVHD in murine models and found that antagonistic anti OX40L moAb or the use of OX40−/−donor or recipient mice resulted in similar reduction in GVHD (79). This evidence concerns the gene TNFSF4 and graft versus host disease.